LYNN MCLAUGHLIN: Open Payments
NPI 1073573184 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,419 in 66 payments from 17 companies in 2025. Trend: 2023 $476 · 2024 $1,383 · 2025 $1,419
Food & beverage: $1,324Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $192 |
| ABBVIE INC. | 9 | $166 |
| Janssen Biotech, Inc. | 5 | $157 |
| E.R. Squibb & Sons, L.L.C. | 7 | $117 |
| LEO Pharma Inc. | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $98 |
| Lilly USA, LLC | 5 | $92 |
| Botanix SB Inc | 4 | $77 |
| Incyte Corporation | 3 | $71 |
| Galderma Laboratories, L.P. | 4 | $65 |
Products named: COSENTYX, TREMFYA, SKYRIZI, Sotyktu, DUPIXENT, TALTZ, SOFDRA, ADBRY.
Industry payments across NE — which companies pay providers there.
